ENDO HEALTH SOLUTIONS INC

Inactive Instrument

Analyst Reco. Endo Health Solutions Inc Nasdaq

Equities

US29264F2056

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mar. 22	Fourth Amended Joint Reorganization Plan Approved for Endo International plc	CI
Mar. 20	Health Care Down on Rate Bias -- Health Care Roundup	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BMO Capital Lowers Price Target for Endo International to $2 From $4, Maintains Market Perform Rating	22-05-09	MT
Barclays Trims Endo International's Price Target to $1 From $2, Maintains Underweight Rating	22-05-09	MT
Piper Sandler Downgrades Endo International to Underweight From Neutral, Lowers PT to $1 From $3	22-05-06	MT
Citigroup Adjusts Endo International's Price Target to $6 From $11, Reiterates Buy Rating	22-03-09	MT
BMO Capital Adjusts Endo International Price Target to $4 From $8, Maintains Market Perform Rating	22-03-03	MT
Piper Sandler Adjusts Endo International Price Target to $3 From $5, Maintains Neutral Rating	22-03-02	MT
Barclays Downgrades Endo International to Underweight from Equalweight, Adjusts Price Target to $2 from $5	22-03-02	MT
Barclays Adjusts Endo International's Price Target to $5 From $7, Keeps Equalweight Rating	21-12-16	MT
Endo International : S&P Downgrades Endo International Rating to 'CCC+' From 'B-' on Vasostrict Trial Outcome; Outlook Negative	21-09-02	MT
ENDO INTERNATIONAL : Piper Sandler Downgrades Endo International to Neutral From Overweight, Adjusts Price Target to $3 From $10	21-08-31	MT
ENDO INTERNATIONAL : RBC Cuts Price Target on Endo International to $5 From $6, Reiterates Sector Perform	21-08-09	MT
ENDO INTERNATIONAL : Citigroup Adjusts Price Target on Endo International to $11 From $10, Maintains Buy Rating	21-05-17	MT
ENDO INTERNATIONAL : RBC Cuts Price Target on Endo International to $6 From $7, Noting 'Persistent Overhang' of Opioid Litigation; Sector Perform Kept	21-05-10	MT
ENDO INTERNATIONAL : Morgan Stanley Adjusts Price Target on Endo International to $7 From $5, Maintains Underweight Rating	21-03-03	MT
ENDO INTERNATIONAL : RBC Capital Adjusts Endo International's Price Target to $7 From $5, Maintains Sector Perform Rating	21-03-01	MT
ENDO INTERNATIONAL : Morgan Stanley Adjusts Price Target on Endo International to $5 From $4, Maintains Underweight Rating	20-12-21	MT
ENDO INTERNATIONAL : Morgan Stanley Lifts Endo International Price Target to $4 From $3, Maintains at Underweight	20-11-12	MT
Wall St. closes at 2016 high as Fed signals fewer rate hikes	16-03-16	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer